Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -69.05x is 179% below its 1-year average of -24.72x, near the low end of its 1-year range (-69.05x–-24.64x).
179.36% below its 12-month average of -24.72x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -24.79x.
INTEREST COVERAGE RATIO
-69.05x
INTEREST COVERAGE RATIO AVG TTM
-24.72x
INTEREST COVERAGE RATIO AVG 3Y
-24.72x
INTEREST COVERAGE RATIO AVG 5Y
-24.72x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-179.36%
CURRENT VS 3Y AVG
-179.36%
CURRENT VS 5Y AVG
-179.36%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-972.20%
vs the sector median at left
ARS Pharmaceuticals, Inc.
Market Cap
$426.51M
Interest Coverage Ratio
-69.05x
TTM Avg
-24.72x
3Y Avg
-24.72x
5Y Avg
-24.72x
Market Cap
$424.10M
Interest Coverage Ratio
-17.61x
TTM Avg
2.56x
3Y Avg
1.47x
5Y Avg
1.63x
Market Cap
$422.86M
Interest Coverage Ratio
-1333.90x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$422.72M
Interest Coverage Ratio
-2.11x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$431.97M
Interest Coverage Ratio
-2.19x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$419.87M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$418.95M
Interest Coverage Ratio
-16.10x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$435.61M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$416.27M
Interest Coverage Ratio
-13.80x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ARS Pharmaceuticals, Inc. (SPRY) | $426.51M | -69.05x | -24.72x | -24.72x | -24.72x |
| NeoGenomics, Inc. (NEO)vs › | $424.10M | -17.61x | 2.56x | 1.47x | 1.63x |
| Tectonic Therapeutic, Inc. (TECX)vs › | $422.86M | -1333.90x | N/A | N/A | N/A |
| Tilray Brands, Inc. (TLRY)vs › | $422.72M | -2.11x | N/A | N/A | N/A |
| NeuroPace, Inc. (NPCE)vs › | $431.97M | -2.19x | N/A | N/A | N/A |
| Prothena Corporation plc (PRTA)vs › | $419.87M | N/A | N/A | N/A | N/A |
| Editas Medicine, Inc. (EDIT)vs › | $418.95M | -16.10x | N/A | N/A | N/A |
| YD Bio Limited Ordinary Shares (YDES)vs › | $435.61M | N/A | N/A | N/A | N/A |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | -13.80x | N/A | N/A | N/A |
| Rezolute, Inc. (RZLT)vs › | $415.98M | N/A | N/A | N/A | N/A |
Interest Coverage
-69.0x
Debt/Equity
13.72
Current Ratio
3.48
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -24.79x |
| 2026-03-31 | -24.64x |
| 2020-06-30 | -1615.75x |
| 2020-03-31 | -141.68x |
| 2019-12-31 | -177.72x |
